Lilly confirms date and conference call for third-quarter 2025 financial results announcement
Eli Lilly (NYSE: LLY) will release its third-quarter 2025 financial results on October 30, 2025.
The company will host a conference call for investors and media on the same day beginning at 10:00 a.m. Eastern time, with a live webcast and a replay available via the investor website at https://investor.lilly.com/webcasts-and-presentations.
Eli Lilly (NYSE: LLY) presenterà i suoi risultati finanziari del terzo trimestre 2025 il 30 ottobre 2025.
L'azienda terrà una conference call per investitori e media nello stesso giorno, a partire dalle 10:00 a.m. ora orientale, con una trasmissione in diretta e una replica disponibili sul sito degli investitori all'indirizzo https://investor.lilly.com/webcasts-and-presentations.
Eli Lilly (NYSE: LLY) divulgará sus resultados financieros del tercer trimestre de 2025 el 30 de octubre de 2025. La empresa celebrará una llamada de conferencia para inversionistas y medios el mismo día, a partir de las 10:00 a.m. hora del Este, con una transmisión en vivo y una repetición disponible a través del sitio web de inversores en https://investor.lilly.com/webcasts-and-presentations.
Eli Lilly (NYSE: LLY)는 2025년 3분기 재무 실적을 2025년 10월 30일에 발표할 예정입니다.
회사는 같은 날 투자자와 언론을 대상으로 컨퍼런스 콜을 개최하며, 동부 표준시 기준 오전 10:00에 시작하고, 생방송과 다시보기가 https://investor.lilly.com/webcasts-and-presentations의 투자자 웹사이트에서 제공됩니다.
Eli Lilly (NYSE: LLY) publiera ses résultats financiers du troisième trimestre 2025 le 30 octobre 2025. L'entreprise organisera une conférence téléphonique à destination des investisseurs et des médias le même jour, à partir de 10h00, heure de l'Est, avec une diffusion en direct et une rediffusion disponible via le site des investisseurs à l'adresse https://investor.lilly.com/webcasts-and-presentations.
Eli Lilly (NYSE: LLY) wird seine Ergebnisse des dritten Quartals 2025 am 30. Oktober 2025 veröffentlichen. Das Unternehmen wird am selben Tag eine Telefonkonferenz für Investoren und Medien veranstalten, beginnend um 10:00 Uhr Eastern Time, mit einem Live-Webcast und einer Wiederholung, verfügbar über die Investorenseite unter https://investor.lilly.com/webcasts-and-presentations.
Eli Lilly (NYSE: LLY) ستعلن عن نتائجها المالية للربع الثالث من عام 2025 في 30 أكتوبر 2025. ستستضيف الشركة مكالمة مؤتمر للمستثمرين ووسائل الإعلام في نفس اليوم ابتداءً من الساعة 10:00 صباحاً بتوقيت شرق الولايات المتحدة، مع بث مباشر وإعادة عرض متاح عبر موقع المستثمرين على العنوان https://investor.lilly.com/webcasts-and-presentations.
伊莱利（NYSE: LLY）将于2025年公布2025年第三季度财务业绩，日期为2025年10月30日。公司将于同日为投资者和媒体举行一个电话会议，时间为美国东部时间上午10:00，并提供现场网络广播和回放，均可通过投资者网站https://investor.lilly.com/webcasts-and-presentations获取。
- None.
- None.
The conference call will begin at 10 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY
Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
|
Refer to: |
Ashley Hennessey; gentry_ashley_jo@lilly.com; 317-416-4363 (Media) |
|
|
Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-third-quarter-2025-financial-results-announcement-302585549.html
SOURCE Eli Lilly and Company
FAQ
When will Eli Lilly (LLY) report Q3 2025 results?
What time is the Eli Lilly (LLY) Q3 2025 conference call?
How can investors join the Eli Lilly (LLY) Q3 2025 webcast?
Will there be a replay of the Eli Lilly (LLY) Q3 2025 conference call?
Who is the audience for the Eli Lilly (LLY) October 30, 2025 call?
